JP2009521908A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009521908A5 JP2009521908A5 JP2008547861A JP2008547861A JP2009521908A5 JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5 JP 2008547861 A JP2008547861 A JP 2008547861A JP 2008547861 A JP2008547861 A JP 2008547861A JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- nucleic acid
- cargo molecule
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 claims 4
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 claims 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 238000002255 vaccination Methods 0.000 claims 2
- 108091023037 Aptamer Proteins 0.000 claims 1
- 102000053642 Catalytic RNA Human genes 0.000 claims 1
- 108090000994 Catalytic RNA Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 102000010445 Lactoferrin Human genes 0.000 claims 1
- 108010063045 Lactoferrin Proteins 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 1
- 229940078795 lactoferrin Drugs 0.000 claims 1
- 235000021242 lactoferrin Nutrition 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000693 micelle Substances 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 108091092562 ribozyme Proteins 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 2
- 102000050459 human LTF Human genes 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 1
- 229940072440 bovine lactoferrin Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05028755.6 | 2005-12-30 | ||
| EP05028755 | 2005-12-30 | ||
| PCT/EP2006/010271 WO2007076904A1 (en) | 2005-12-30 | 2006-10-25 | Peptides useful as cell-penetrating peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009521908A JP2009521908A (ja) | 2009-06-11 |
| JP2009521908A5 true JP2009521908A5 (enExample) | 2011-06-30 |
| JP5264502B2 JP5264502B2 (ja) | 2013-08-14 |
Family
ID=37491778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008547861A Active JP5264502B2 (ja) | 2005-12-30 | 2006-10-25 | 細胞透過性ペプチドとして使用できるペプチド |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20100061932A1 (enExample) |
| EP (1) | EP1966240B3 (enExample) |
| JP (1) | JP5264502B2 (enExample) |
| KR (1) | KR101317100B1 (enExample) |
| CN (1) | CN101395180B (enExample) |
| AT (1) | ATE501169T1 (enExample) |
| AU (1) | AU2006332193B2 (enExample) |
| BR (1) | BRPI0620806B8 (enExample) |
| CA (1) | CA2646833C (enExample) |
| DE (1) | DE602006020617D1 (enExample) |
| ES (1) | ES2361621T7 (enExample) |
| IL (1) | IL192131A (enExample) |
| MX (1) | MX2008008548A (enExample) |
| PL (1) | PL1966240T6 (enExample) |
| SI (1) | SI1966240T1 (enExample) |
| WO (1) | WO2007076904A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005051366A1 (de) | 2005-10-25 | 2007-04-26 | Degussa Gmbh | Drug Delivery Systeme |
| EP2050461A1 (en) | 2007-10-19 | 2009-04-22 | PharmaSurgics in Sweden AB | Peptides based on the sequence of human lactoferrin and their use |
| EP2090584A1 (en) * | 2008-02-13 | 2009-08-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Identification of a novel cysteine-rich cell penetrating peptide |
| RU2470666C2 (ru) * | 2008-02-28 | 2012-12-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для трансназального введения |
| CN102869384B (zh) | 2009-06-22 | 2016-01-13 | 伯纳姆医学研究所 | 使用带有c-端元件的肽和蛋白质的方法和组合物 |
| JP5818319B2 (ja) * | 2009-12-14 | 2015-11-18 | 国立大学法人北海道大学 | 脂質膜構造体に細胞透過能を付与および/または脂質膜構造体の細胞透過能を増強するペプチド、ならびにそれらペプチドと結合した脂質を構成脂質として含む、細胞透過能を有するまたは細胞透過能が増強された脂質膜構造体 |
| WO2011084061A1 (en) | 2010-01-08 | 2011-07-14 | Universitair Medisch Centrum St. Radboud | Cpp (cell penetrating peptide) and its uses |
| FR2955773B1 (fr) * | 2010-02-01 | 2017-05-26 | Commissariat Energie Atomique | Complexe moleculaire de ciblage des antigenes vers les cellules presentatrices d'antigene et ses applications pour la vaccination |
| US9724422B2 (en) * | 2010-11-26 | 2017-08-08 | Evonik Roehm Gmbh | Human lactoferrin derived peptide for use as an antigen masking agent |
| CN102174078A (zh) * | 2011-01-10 | 2011-09-07 | 中国药科大学 | 肿瘤细胞选择性穿膜肽的应用 |
| CN102091036A (zh) * | 2011-01-10 | 2011-06-15 | 中国药科大学 | 一种含有抗肿瘤药物的复合脂质体及其制备方法和用途 |
| CN102153629B (zh) * | 2011-01-20 | 2013-07-24 | 华中科技大学 | 一种短肽及其应用 |
| WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
| EP2715291A4 (en) | 2011-05-31 | 2015-10-21 | Airware Inc | NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR) |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| CN102988295B (zh) * | 2011-09-09 | 2015-07-29 | 复旦大学 | 一种穿膜肽修饰的纳米粒及其制备方法 |
| CN102993296A (zh) * | 2011-09-14 | 2013-03-27 | 广州格拉姆生物科技有限公司 | 牛乳铁蛋白肽及其制备方法 |
| WO2013052058A1 (en) * | 2011-10-07 | 2013-04-11 | Morehouse School Of Medicine | Antimicrobial compositions and methods of use thereof |
| US8669226B2 (en) | 2011-10-07 | 2014-03-11 | Morehouse School Of Medicine | Antimicrobial compositions and methods of use thereof |
| US12083158B2 (en) | 2011-10-07 | 2024-09-10 | Morehouse School Of Medicine | Antibacterial compositions, methods of making and use thereof |
| DE102011055229A1 (de) | 2011-11-10 | 2013-05-16 | Evonik Degussa Gmbh | Verfahren zur Bereitstellung von Regelleistung mit einem Energiespeicher unter Ausnutzung von Toleranzen bei der Bestimmung der Frequenzabweichung |
| DE102011055231A1 (de) * | 2011-11-10 | 2013-05-16 | Evonik Industries Ag | Verfahren zur Bereitstellung von Regelleistung |
| US9259483B2 (en) | 2011-11-24 | 2016-02-16 | Positec Power Tools (Suzhou) Co Ltd | Peptide sequence design and use thereof for peptide-mediated siRNA delivery |
| CN103169982B (zh) * | 2011-12-23 | 2015-05-20 | 中国科学院上海药物研究所 | 生物活性肽修饰的纳米银及其制备方法和用途 |
| CN103382217B (zh) * | 2012-12-11 | 2015-05-27 | 任发政 | 穿膜肽和药物组合物及其制备方法和应用 |
| US9642895B2 (en) | 2013-08-12 | 2017-05-09 | 3M Innovative Properties Company | Peptides for enhancing transdermal delivery |
| WO2015075747A1 (en) * | 2013-11-19 | 2015-05-28 | Council Of Scientific And Industrial Research | Cell-penetrating peptide for biomolecule delivery |
| WO2015089487A1 (en) | 2013-12-12 | 2015-06-18 | Life Technologies Corporation | Membrane-penetrating peptides to enhance transfection and compositions and methods for using same |
| CN103784406A (zh) * | 2014-01-20 | 2014-05-14 | 同济大学 | 一种偶联穿膜肽和mmp酶切位点的纳米颗粒 |
| ES2767501T3 (es) * | 2014-05-28 | 2020-06-17 | Evonik Operations Gmbh | Nanopartícula |
| US10793603B2 (en) * | 2015-02-27 | 2020-10-06 | Josho Gakuen Educational Foundation | Polysaccharide derivative having membrane-permeable peptide chain |
| KR101647804B1 (ko) * | 2015-06-24 | 2016-08-11 | 한국과학기술연구원 | 신규 세포투과 펩타이드 및 이의 용도 |
| CN108456254B (zh) * | 2017-02-20 | 2021-06-01 | 中国科学院上海药物研究所 | 一种tcs-穿膜肽-肿瘤蛋白酶底物肽融合蛋白、其制备方法和用途 |
| EP3628047A1 (en) | 2017-05-02 | 2020-04-01 | Sanford Burnham Prebys Medical Discovery Institute | Tumor associated monocyte/macrophage binding peptide and methods of use thereof |
| CN108101966B (zh) * | 2017-12-26 | 2020-10-27 | 暨南大学 | 基于细胞穿膜肽的氧化还原敏感多肽及其在疫苗载体中的应用 |
| EP3790534B1 (en) | 2018-05-08 | 2023-08-30 | Evonik Operations GmbH | Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide |
| CN111499759B (zh) * | 2019-01-31 | 2022-12-20 | 上海科技大学 | 一种具有细胞穿膜性的锌指蛋白-乳铁蛋白融合蛋白质及其制备与应用 |
| EP3921329A1 (en) | 2019-02-04 | 2021-12-15 | University of Tartu | Bi-specific extracellular matrix binding peptides and methods of use thereof |
| CN110078834B (zh) * | 2019-05-05 | 2021-07-30 | 华中科技大学 | 一种类短肽、辅助透膜剂及其应用 |
| CN112426438B (zh) * | 2019-11-14 | 2023-12-05 | 上海鑫湾生物科技有限公司 | 用于调控酸性环境免疫应答的组合物、其制备方法和用途 |
| BR112022019370A2 (pt) * | 2020-03-27 | 2022-11-29 | Alastin Skincare Inc | Composições e métodos relativos à pigmentação |
| IL315874A (en) | 2022-03-30 | 2024-11-01 | Evonik Operations Gmbh | Formulations consisting of cationic lipids and poly(lactic-co-glycolic acid) for delivery of polynucleotides to cells |
| EP4601700A1 (en) * | 2022-10-13 | 2025-08-20 | Stichting Radboud universitair medisch centrum | A complex comprising a cargo and a targeting moiety binding intelectin-1 |
| CN120641131A (zh) | 2022-12-01 | 2025-09-12 | 耶鲁大学 | 用于细胞内有效载荷递送的刺激反应性无痕工程化平台 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5633076A (en) * | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| JP2818056B2 (ja) | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
| JP3207535B2 (ja) * | 1992-08-07 | 2001-09-10 | 森永乳業株式会社 | 抗酸化剤 |
| JP3312946B2 (ja) * | 1993-03-04 | 2002-08-12 | 雪印乳業株式会社 | ウイルス感染・増殖抑制剤 |
| JP2001504448A (ja) | 1996-08-30 | 2001-04-03 | フュルステ,イェンス,ペーター | 核酸の鏡面対称選択および進化 |
| US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| US6958239B2 (en) | 1996-11-21 | 2005-10-25 | Oligos Etc Inc. | Three component chimeric antisense oligonucleotides |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| SE9804614A0 (en) * | 1998-07-06 | 2000-01-07 | A+ Science Invest Ab | New peptides and use thereof |
| AU4656999A (en) | 1998-07-15 | 2000-02-07 | Samyang Genex Corporation | Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof |
| JP3681982B2 (ja) * | 1998-07-15 | 2005-08-10 | サムヤン ジェネックス コーポレイション | 酵母からラクトフェリンポリペプチドを大量生産する方法及びそれに有用な微生物菌株 |
| GB9818938D0 (en) * | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| EP1309726B2 (en) | 2000-03-30 | 2018-10-03 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
-
2006
- 2006-10-25 MX MX2008008548A patent/MX2008008548A/es active IP Right Grant
- 2006-10-25 KR KR1020087015786A patent/KR101317100B1/ko active Active
- 2006-10-25 JP JP2008547861A patent/JP5264502B2/ja active Active
- 2006-10-25 CN CN200680049953.0A patent/CN101395180B/zh active Active
- 2006-10-25 AT AT06806526T patent/ATE501169T1/de active
- 2006-10-25 DE DE602006020617T patent/DE602006020617D1/de active Active
- 2006-10-25 PL PL06806526T patent/PL1966240T6/pl unknown
- 2006-10-25 EP EP06806526A patent/EP1966240B3/en active Active
- 2006-10-25 AU AU2006332193A patent/AU2006332193B2/en active Active
- 2006-10-25 WO PCT/EP2006/010271 patent/WO2007076904A1/en not_active Ceased
- 2006-10-25 BR BRPI0620806A patent/BRPI0620806B8/pt active IP Right Grant
- 2006-10-25 SI SI200631008T patent/SI1966240T1/sl unknown
- 2006-10-25 CA CA2646833A patent/CA2646833C/en active Active
- 2006-10-25 US US12/159,226 patent/US20100061932A1/en not_active Abandoned
- 2006-10-25 ES ES06806526T patent/ES2361621T7/es active Active
-
2008
- 2008-06-12 IL IL192131A patent/IL192131A/en active IP Right Grant
-
2012
- 2012-07-25 US US13/557,706 patent/US9403884B2/en active Active
-
2015
- 2015-12-01 US US14/955,696 patent/US20160151504A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009521908A5 (enExample) | ||
| JP6077543B2 (ja) | ペプチド | |
| KR101317100B1 (ko) | 세포-침투성 펩티드로서 유용한 펩티드 | |
| Zhang et al. | Instructive design of triblock peptide amphiphiles for structurally complex micelle fabrication | |
| AU2012303619B2 (en) | Pathogen and substance traps | |
| EP2594581A3 (en) | Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens | |
| KR20240172763A (ko) | 핵산 및/또는 단백질 적재물 전달을 위한 조성물 및 방법 | |
| Zhang et al. | Recent advances of cell-penetrating peptides and their application as vectors for delivery of peptide and protein-based cargo molecules | |
| KR20180064534A (ko) | 조건부 활성 폴리펩티드 | |
| JP2013504589A5 (enExample) | ||
| CN104736181A (zh) | 包含靶向聚氨基酸与脂肪酸之缀合物的药物递送载剂 | |
| CN102256999A (zh) | 向白细胞的有效转运 | |
| WO2008039483A3 (en) | Modified self-assembling peptides | |
| JP2014504150A5 (enExample) | ||
| Hou et al. | Co-delivery of siPTPN13 and siNOX4 via (myo) fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy | |
| KR101647804B1 (ko) | 신규 세포투과 펩타이드 및 이의 용도 | |
| JP2015522264A5 (enExample) | ||
| Platt et al. | Stapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptors | |
| JP2025028940A (ja) | 界面活性ペプチドナノ構造および薬物送達における使用 | |
| JP2008538280A5 (enExample) | ||
| WO2011135222A3 (fr) | Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles | |
| F Nahhas et al. | Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics | |
| JP2022502347A (ja) | 細胞透過性ペプチド | |
| CN116724059A (zh) | 用于治疗病毒感染的组合物和方法 | |
| CN115243699A (zh) | 分子导向系统肽及其用途 |